Traumatic stress in acute leukemia

Psycho-Oncology

Volumn 22, Issue 2, 2013, Pages 299-307

  Rodin, Gary ^a,c,d   Yuen, Dora ^a,c   Mischitelle, Ashley ^a,c   Minden, Mark D ^a,b,e   Brandwein, Joseph ^a,b,e   Schimmer, Aaron ^a,b,e   Marmar, Charles ^g   Gagliese, Lucia ^a,c,f   Lo, Christopher ^a,c,d   Rydall, Anne ^a,c   Zimmermann, Camilla ^a,c,e  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f YORK UNIVERSITY   (Canada)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute leukemia; cancer; hematological malignancies; psychosocial oncology; supportive care; traumatic stress

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; GEMTUZUMAB; HYDROXYUREA; MIDOSTAURIN; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE STRESS REACTION QUESTIONNAIRE; ADULT; ARTICLE; CANADA; CANCER CENTER; COMMUNICATION DISORDER; CORRELATION ANALYSIS; DISTRESS SYNDROME; FEMALE; HEALTH CARE PERSONNEL; HOPELESSNESS; HUMAN; INDEPENDENT VARIABLE; LEUKEMIA RELAPSE; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEMORIAL SYMPTOM ASSESSMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT SATISFACTION; POSTTRAUMATIC STRESS DISORDER; PREDICTOR VARIABLE; PREVALENCE; PROMYELOCYTIC LEUKEMIA; PSYCHOSOCIAL DISORDER; RELIGION; SELF ESTEEM; SOCIAL SUPPORT; SYMPTOM; TREATMENT FAILURE;

ADULT; AGED; CANADA; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PAIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84873410889     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2092     Document Type: Article

References (52)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Text Revision (DSM-IV-TR). American Psychiatric Association Press: Washington. 2000.
2. Spiegel D,. Treatment of acute traumatic stress reactions. J Trauma Dissociation 2005; 6: 101-108.
3. Gradus JL, Qin P, Lincoln AK, et al,. Acute stress reaction and completed suicide. Int J Epidemiol 2010; 39: 1478-1484.
4. Friedman MJ, Resick PA, Keane TM,. PTSD: Twenty-five years of progress and challenges. In Handbook of PTSD: Science and Practice, Friedman MJ, Keane TM, Resick PA, (eds.), Guilford Press: New York, 2007; 3-18.
5. Galea S, Nandi A, Vlahov D,. The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev 2005; 27: 78-91.
6. Boscarino JA, Adams RE,. PTSD onset and course following the World Trade Center disaster: findings and implications for future research. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 887-898.
7. Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D,. Measuring spiritual well-being in people with cancer: the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp). Ann Behav Med 2002; 24: 49-58.
8. Hobfoll SE, Watson P, Bell CC, et al,. Five essential elements of immediate and mid-term mass trauma intervention: empirical evidence. Psychiatry 2007; 70: 283-315.
9. Kangas M, Henry JL, Bryant RA,. The relationship between acute stress disorder and posttraumatic stress disorder following cancer. J Consult Clin Psychol 2005; 73: 360-364.
10. Kornblith AB, Mirabeau-Beale K, Lee H, et al,. Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease. J Psychosoc Oncol 2010; 28: 451-469.
11. Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y,. Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol 2004; 22: 1957-1965.
12. Kaasa S, Malt UF, Hagen S, Wist E, Moum T, Kvikstad A,. Psychological distress in cancer patients with advanced disease. Radiother Oncol 1993; 27: 193-197.
13. Hampton MR, Frombach I,. Women's experience of traumatic stress in cancer treatment. Health Care Women Int 2000; 21: 67-76.
14. Andrykowski MA, Cordova MJ, McGrath PC, Sloan DA, Kenady DE,. Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psycho-Oncology 2000; 9: 69-78.
15. Butler LD, Koopman C, Classen C, Spiegel D,. Traumatic stress, life events, and emotional support in women with metastatic breast cancer: cancer-related traumatic stress symptoms associated with past and current stressors. Health Psychol 1999; 18: 555-560.
16. Lewis JA, Manne SL, DuHamel KN, et al,. Social support, intrusive thoughts, and quality of life in breast cancer survivors. J Behav Med 2001; 24: 231-245.
17. Smith MY, Redd WH, Peyser C, Vogl D,. Post-traumatic stress disorder in cancer: a review. Psycho-Oncology 1999; 8: 521-537.
18. Gurevich M, Devins GM, Wilson C, McCready D, Marmar CR, Rodin GM,. Stress response syndromes in women undergoing mammography: a comparison of women with and without a history of breast cancer. Psychosom Med 2004; 66: 104-112.
19. Han WT, Collie K, Koopman C, et al,. Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psycho-Oncology 2005; 14: 318-330.
20. Benoit M, Bouthillier D, Moss E, Rousseau C, Brunet A,. Emotion regulation strategies as mediators of the association between level of attachment security and PTSD symptoms following trauma in adulthood. Anxiety Stress Coping 2010; 23: 101-118.
21. Rodin G, Walsh A, Zimmermann C, et al,. The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancer. Psycho-Oncology 2007; 16: 1080-1091.
22. Santos FR, Kozasa EH, Chauffaille Mde L, Colleoni GW, Leite JR,. Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. J Psychosom Res 2006; 60: 505-511.
23. Smith SK, Zimmerman S, Williams CS, Preisser JS, Clipp EC,. Post-traumatic stress outcomes in non-Hodgkin's lymphoma survivors. J Clin Oncol 2008; 26: 934-941.
24. Brandwein JM, Hedley DW, Chow S, et al,. A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response. Leukemia 2011; 25: 945-952.
25. Roberts NP, Kitchiner NJ, Kenardy JA, Bisson JI,. Early psychological interventions to treat acute traumatic stress symptoms. Cochrane Database Syst Rev 2010; 3: CD007944.
26. Kornør H, Winje D, Ekeberg Ø, et al,. Early trauma-focused cognitive-behavioural therapy to prevent chronic post-traumatic stress disorder and related symptoms: a systematic review and meta-analysis. BMC Psychiatry 2008; 8: 81.
27. Seery MD, Holman EA, Silver RC,. Whatever does not kill us: cumulative lifetime adversity, vulnerability, and resilience. J Pers Soc Psychol 2010; 99: 1025-1041.
28. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H,. Validation of a Short Orientation-Memory-Concentration test of cognitive impairment. Am J Psychiatry 1983; 140: 734-739.
29. Cardeña E, Koopman C, Classen C, Spiegel D,. Review of the Stanford Acute Stress Reaction Questionnaire (SASRQ). In Measurement of Stress, Trauma and Adaptation, Stamm BH, (ed.), Sidran Press: Lutherville, 1996; 293-297.
30. Cardeña E, Koopman C, Classen C, Waelde LC, Spiegel D,. Psychometric properties of the Stanford Acute Stress Reaction Questionnaire (SASRQ): a valid and reliable measure of acute stress. J Trauma Stress 2000; 13: 719-734.
31. Cardeña E, Spiegel D,. Dissociative reactions to the San Francisco Bay Area earthquake of 1989. Am J Psychiatry 1993; 150: 474-478.
32. Freinkel A, Koopman C, Spiegel D,. Dissociative symptoms in media eyewitnesses of an execution. Am J Psychiatry 1994; 151: 1335-1339.
33. Koopman C, Gore-Felton C, Classen C, Kim P, Spiegel D,. Acute stress reactions to everyday stressful life events among sexual abuse survivors with PTSD. J Child Sex Abuse 2001; 10: 83-99.
34. Karnofsky DA, Burchenal JH,. The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, Macleod CM, (ed.), Columbia University Press: New York, 1947; 191-205.
35. Portenoy RK, Thaler HT, Kornblith AB, et al,. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A: 1326-1336.
36. Storring JM, Minden MD, Kao S, et al,. Treatment of adults with BCR-ABL negative acute lymphoblastic leukemia with a modified pediatric regimen. Br J Haematol 2009; 146: 76-85.
37. Kantarjian HM, O'Brien S, Smith TL, et al,. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547-561.
38. Brandwein JM, Gupta V, Schuh AC, et al,. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy. Am J Hematol 2007; 83: 54-58.
39. Amadori S, Arcese W, Isacchi G, et al,. Mitoxantrone, etoposide and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia. J Clin Oncol 1991; 9: 1210-1214.
40. Beck AT, Weissman A, Lester D, Trexler L,. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42: 861-865.
41. Rosenfeld B, Breitbart W, Galietta M, et al,. The schedule of attitudes toward hastened death: measuring desire for death in terminally ill cancer patients. Cancer 2000; 88: 2868-2875.
42. Breitbart W,. Spirituality and meaning in supportive care: spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. Support Care Cancer 2002; 10: 272-280.
43. Cella DF, Tulsky DS, Gray G, et al,. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
44. Rosenberg M., Conceiving the Self, Basic Books: New York, 1979.
45. Lo C, Walsh A, Mikulincer M, Gagliese L, Zimmermann C, Rodin G,. Measuring attachment security in patients with advanced cancer: psychometric properties of a modified and brief Experiences in Close Relationships scale. Psycho-Oncology 2009; 18: 490-499.
46. Sherbourne CD, Stewart AL,. The MOS social support survey. Soc Sci Med 1991; 32: 705-714.
47. Schag CA, Heinrich RL,. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990; 4: 135-138.
48. McKibben JB, Bresnick MG, Wiechman Askay SA, Fauerbach JA,. Acute stress disorder and posttraumatic stress disorder: a prospective study of prevalence, course, and predictors in a sample with major burn injuries. J Burn Care Res 2008; 29: 22-35.
49. Rodin G, Mackay JA, Zimmermann C, et al,. Clinician-patient communication: a systematic review. Support Care Cancer 2009; 17: 627-644.
50. Rodin G, Zimmermann C, Rydall A, et al,. The desire for hastened death in patients with metastatic cancer. J Pain Symptom Manage 2007; 33: 661-675.
51. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE,. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
52. The Lancet Oncology. Cancer survivors: still room for improvement (Editorial). Lancet Oncol 2011; 12: 609.